The Efficacy and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
A clinical study to compare the safety and effectiveness of two different dose ranges of
risperidone solution in the treatment of adolescents with a diagnosis of schizophrenia.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.